中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Polysaccharides from Lycium barbarum ameliorate amyloid pathology and cognitive functions in APP/PS1 transgenic mice

文献类型:期刊论文

作者Zhou, Yue1; Duan, Yanhong2; Huang, Shichao4; Zhou, Xuan2; Zhou, Lishuang5; Hu, Tingting1; Yang, Yongfeng1; Lu, Jing1; Ding, Kan5; Guo, Dean6
刊名INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
出版日期2020-02-01
卷号144页码:1004-1012
关键词Lycium barbarum polysaccharides Alzheimer's disease Amyloid-beta Synaptic plasticity Neuropathology
ISSN号0141-8130
DOI10.1016/j.ijbiomac.2019.09.177
通讯作者Ding, Kan(dingkan@simm.ac.cn) ; Guo, Dean(daguo@simm.ac.cn) ; Cao, Xiaohua(xhcao@brain.ecnu.edu.cn) ; Pei, Gang(gpei@sibs.ac.cn)
英文摘要Alzheimer's disease (AD) is the most common degenerative disease of the central nervous system. It is associated with abnormal accumulation of amyloid-beta (A beta) plaques, impaired neurogenesis, and damaged cognitive functions. We have known for a long time that natural compounds and their derivatives have gained increasing attention in AD drug research due to their multiple effects and inherently enormous chemicals. In this study, we will demonstrate that polysaccharides from L. barbarum (LBP1), a traditional natural compound, can reduce A beta level and improve the cognitive functions in APP/PSI transgenic mouse. LBP1 can enhance neurogenesis as indicated by BrdU/NeuN double labeling. Furthermore, it can restore synaptic dysfunction at hippocampus CA3-CA1 pathway. Additionally, in vitro cell assay indicates that LBP1 may affect A beta processing. In conclusion, our study indicates that LBP1 might be a potential therapeutic agent for the treatment of AD against multiple targets that include synaptic plasticity, A beta pathology and neuropathology. (C) 2019 The Authors. Published by Elsevier B.V.
WOS关键词SYNAPTIC PLASTICITY ; BETA ; FRUITS ; OLIGOMERS ; L. ; NEUROGENESIS ; TOXICITY ; CELLS
资助项目National Key Research and Development Program of China[2018YFA0108003] ; Strategic Priority Research Program of the Chinese Academy of Sciences[XDA16010309] ; Ministry of Science and Technology[2015CB964502] ; MOST China-Israel cooperation[2016YFE0130500]
WOS研究方向Biochemistry & Molecular Biology ; Chemistry ; Polymer Science
语种英语
WOS记录号WOS:000515200700103
出版者ELSEVIER
源URL[http://119.78.100.183/handle/2S10ELR8/281563]  
专题中国科学院上海药物研究所
通讯作者Ding, Kan; Guo, Dean; Cao, Xiaohua; Pei, Gang
作者单位1.Univ Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci, State Key Lab Cell Biol,Chinese Acad Sci, 320 Yueyang Rd, Shanghai 200031, Peoples R China
2.East China Normal Univ, Shanghai Key Lab Brain Funct Genom, Sch Life Sci, Key Lab Brain Funct Genom,Minist Educ, Shanghai, Peoples R China
3.Tongji Univ, Shanghai Key Lab Signaling & Dis Res, Sch Life Sci & Technol, Collaborat Innovat Ctr Brain Sci, Shanghai 200092, Peoples R China
4.Tongji Univ, Sch Life Sci & Technol, Collaborat Innovat Ctr Brain Sci, Shanghai 200092, Peoples R China
5.Chinese Acad Sci, Shanghai Inst Mat Medica, Glycochem & Glycobiol Lab, Shanghai 201203, Peoples R China
6.Chinese Acad Sci, Shanghai Res Ctr Modernizat Tradit Chinese Med, Shanghai Inst Mat Medica, Natl Engn Lab TCM Standardizat Technol, Shanghai 201203, Peoples R China
7.Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing 100101, Peoples R China
推荐引用方式
GB/T 7714
Zhou, Yue,Duan, Yanhong,Huang, Shichao,et al. Polysaccharides from Lycium barbarum ameliorate amyloid pathology and cognitive functions in APP/PS1 transgenic mice[J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES,2020,144:1004-1012.
APA Zhou, Yue.,Duan, Yanhong.,Huang, Shichao.,Zhou, Xuan.,Zhou, Lishuang.,...&Pei, Gang.(2020).Polysaccharides from Lycium barbarum ameliorate amyloid pathology and cognitive functions in APP/PS1 transgenic mice.INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES,144,1004-1012.
MLA Zhou, Yue,et al."Polysaccharides from Lycium barbarum ameliorate amyloid pathology and cognitive functions in APP/PS1 transgenic mice".INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES 144(2020):1004-1012.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。